Skip to Content

Mdechem Inc MDKM

Morningstar Rating
$0.00 0.00 (97.06%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MDKM is trading at a 64% discount.
Price
$0.00
Fair Value
$5.82
Uncertainty
Extreme
1-Star Price
$8.79
5-Star Price
Economic Moat
Jgxp
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MDKM is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.27
Market Cap
$22.22
Volume/Avg
15,000 / 15,000

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Mdechem Inc is a chemical manufacturing company. The company's product include Sandklene 950 a U.S. patented chemical solution that recovers hydrocarbons from tar/oil sands, Diesel Clean Power 500 an EPA verified technology making engines operate more effectively while using less fuel and reducing emission pollutants and Phosfamid patented chemical solution that inhibits metal corrosion and reduces friction.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Total Number of Employees

Valuation

Metric
MDKM
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
MDKM
Quick Ratio
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
MDKM
Return on Assets (Normalized)
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRHlgf$550.2 Bil
VRTX
Vertex Pharmaceuticals IncWrjsl$111.1 Bil
REGN
Regeneron Pharmaceuticals IncWfwtvn$107.7 Bil
MRNA
Moderna IncGpynp$36.9 Bil
ARGX
argenx SE ADRLtcfh$24.2 Bil
BNTX
BioNTech SE ADRYhwth$22.3 Bil
ALNY
Alnylam Pharmaceuticals IncZxkfmy$19.9 Bil
BMRN
Biomarin Pharmaceutical IncMtxzjb$17.2 Bil
RPRX
Royalty Pharma PLC Class AClxjfy$13.9 Bil
INCY
Incyte CorpHtnktcx$13.6 Bil

Sponsor Center